News
News
- Krystal Biotech Provides Update on Operational Progress and Reports Fourth Quarter and Full Year 2020 Financial Results
14:37 - GlobeNewswire - Checkpoint Therapeutics Announces Formation of Scientific Advisory Board
14:30 - GlobeNewswire - Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
14:30 - GlobeNewswire - Yield10 Bioscience to Present at Bank of America 2021 Virtual Global Agriculture & Materials Conference on March 4, 2021
14:30 - GlobeNewswire - 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round
14:07 - GlobeNewswire - VYNE Therapeutics Announces Development Program for FMX114 Combination Topical Gel for Mild-to-Moderate Atopic Dermatitis
14:00 - GlobeNewswire - EG 427 announces €12 million Series A financing to advance its HSV-1 based gene therapy
14:00 - GlobeNewswire - First High-Plex Spatial Omics Workflow with Integrated Single-Cell Analysis Now Available
14:00 - GlobeNewswire - Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
14:00 - GlobeNewswire - SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Support Advancing a Novel Genome Engineering Platform for Non-Viral Gene Therapy
14:00 - GlobeNewswire
Real-time